Tridek-One Therapeutics, a biotech firm based in Paris, adopted the MyGlo® Reagent Reader to enhance their workflow for developing CD31 checkpoint therapies. This compact, portable luminometer integrated with the ProNect® Data Platform allowed seamless data access and swift luminescence readings, significantly improving efficiency and independence in their research projects. The post Compact Design, Big Impact: Tridek-One Therapeutics Leverages MyGlo® to Accelerate Discovery of Immunomodulating